QUBT Stock Analysis: Quantum Computing | NASDAQ
Computer Hardware | NASDAQ, USA | Market Cap: 1.553m USD | 12M Return: -50.4% | US74766W1080 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.4M
Qual. Beats: 0
Rev. Trend: 80.8%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Quantum Computing Inc. (NASDAQ: QUBT) is a U.S.-based integrated photonics company that supplies quantum machines and optical components to commercial and government customers. Its core technology centers on thin-film lithium niobate (TFLN), a material widely used in photonic integrated circuits for high-speed electro-optical modulation and frequency conversion. The company produces chips for electro-optical modulators, periodically poled devices, and micro-ring resonator cavities.
QUBT is also developing the Entropy Quantum Computer (EQC), which applies its Core Photonics Technology to complex optimization problems. Alongside this, the company offers Emucore and Neurawave, reservoir computing systems aimed at recurrent neural network applications - a class of machine learning architectures that are well suited to photonic hardware because of their parallel, time-series oriented processing. Additional products include LiDAR systems designed to operate in adverse weather (fog, snow, ice), a quantum photonic vibrometer for remote sensing, and quantum networking and authentication solutions.
QUBT is headquartered in Hoboken, New Jersey, was founded in 2001, and is classified within the Information Technology sector under the Electronic Equipment & Instruments sub-industry. The company operates in the emerging quantum and photonic hardware market, addressing use cases in optimization, sensing, secure communications, and machine learning inference.
- Government defense contracts awarded for TFLN photonic chips
- Competition intensifies from IBM Google and pure-play quantum peers
- Dilutive equity offerings fund mounting cash burn
| Net Income: -32.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 5.32 > 1.0 |
| NWC/Revenue: 4.84k% < 20% (prev 102k%; Δ -97.6k% < -1%) |
| CFO/TA -0.03 > 3% & CFO -46.0m > Net Income -32.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 53.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (225.4m) vs 12m ago 35.13% < -2% |
| Gross Margin: -8.22% > 18% (prev 36.45%; Δ -44.67% > 0.5%) |
| Asset Turnover: 1.50% > 50% (prev 0.06%; Δ 1.44% > 0%) |
| Interest Coverage Ratio: -311.4 > 6 (EBIT TTM -94.4m / Interest Expense TTM 303k) |
| A: 0.56 (Total Current Assets 934.4m - Total Current Liabilities 17.5m) / Total Assets 1.63b |
| B: -0.15 (Retained Earnings -250.1m / Total Assets 1.63b) |
| C: -0.07 (EBIT TTM -94.4m / Avg Total Assets 1.26b) |
| D: 33.12 (Book Value of Equity 1.58b / Total Liabilities 47.7m) |
| Altman-Z'' = 37.46 = AAA |
| DSRI: 1.09 (Receivables 18.5m/491k, Revenue 18.9m/546k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.07 (AQ_t 0.38 / AQ_t-1 0.36) |
| SGI: 34.69 (Revenue 18.9m / 546k) |
| TATA: 0.01 (NI -32.5m - CFO -46.0m) / TA 1.63b) |
| Beneish M = 21.25 (Cap -4..+1) = D |
As of November 11, 2026, the stock is trading at USD 6.30 with a total of 9,437,018 shares traded. Over the past week, the price has changed by -2.02%, over one month by -9.09%, over three months by -29.45% and over the past year by -50.39%.
Current recommended Stop Loss: 5.70 (which is 9.5% or 1.2 ATR below the current price).
Quantum Computing has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy QUBT.
- StrongBuy: 4
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 18.7 | 196.3% |
P/S = 158.0557
P/B = 0.9
Revenue TTM = 18.9m USD
EBIT TTM = -94.4m USD
EBITDA TTM = -89.4m USD
Long Term Debt = unknown (none)
Short Term Debt = 2.29m USD (from shortTermDebt, two quarters ago)
Debt = 45.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 21.1m
Net Debt = -855.8m USD (calculated: Debt 45.8m - CCE 901.6m)
Enterprise Value = 696.9m USD (1.55b + Debt 45.8m - CCE 901.6m)
Interest Coverage Ratio = -311.4 (Ebit TTM -94.4m / Interest Expense TTM 303k)
EV/FCF = -25.49x (Enterprise Value 696.9m / FCF TTM -27.3m)
FCF Yield = -3.92% (FCF TTM -27.3m / Enterprise Value 696.9m)
FCF Margin = -144.4% (FCF TTM -27.3m / Revenue TTM 18.9m)
Net Margin = -171.6% (Net Income TTM -32.5m / Revenue TTM 18.9m)
Gross Margin = -8.22% ((Revenue TTM 18.9m - Cost of Revenue TTM 20.5m) / Revenue TTM)
Gross Margin QoQ = 4.51% (prev -21.01%)
Tobins Q-Ratio = 0.43 (Enterprise Value 696.9m / Total Assets 1.63b)
Interest Expense / Debt = 0.66% (Interest Expense 303k / Debt 45.8m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -74.5m (EBIT -94.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 44.10 (Total Current Assets 934.4m / Total Current Liabilities 21.2m)
Debt / Equity = 0.03 (Debt 45.8m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 9.57 (negative EBITDA) (Net Debt -855.8m / EBITDA -89.4m)
Debt / FCF = 31.30 (negative FCF - burning cash) (Net Debt -855.8m / FCF TTM -27.3m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.57% (Net Income -32.5m / Total Assets 1.63b)
RoE = -2.04% (Net Income TTM -32.5m / Total Stockholder Equity 1.59b)
RoCE = -5.86% (EBIT -94.4m / Capital Employed (Total Assets 1.63b - Current Liab 17.5m))
RoIC = -4.63% (negative operating profit) (NOPAT -74.5m / Invested Capital 1.61b)
WACC = 4.84% (E(1.55b)/V(1.60b) * Re(4.97%) + D(45.8m)/V(1.60b) * Rd(0.66%) * (1-Tc(0.21)))
Discount Rate = 4.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.55 | Cagr: 47.23%
[DCF] Fair Price = unknown (Cash Flow -27.3m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.06 | # QB: 0
Revenue Correlation: 80.80 | Revenue CAGR: 274.2% | SUE: 4.0 | # QB: 3
EPS current Year (2026-12-31): EPS=-0.23 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+28.0% | GrowthRev=+4100.5%
EPS next Year (2027-12-31): EPS=-0.24 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=-1.4% | GrowthRev=+74.6%
[Analyst] Revisions Ratio: +25% (up=1, down=0)